Clinical Trials Logo
  1. Home
  2. Peripheral Vascular Disease
  3. NCT02418156
  4. Details
NCT02418156 Clinical Trial

A Study on the Use of CorMatrix® ECM® for Femoral Arterial Reconstruction

Peripheral Vascular Disease Clinical Trial

— PERFORM  

Official title:
A Post Market Observational Study on the Use of CorMatrix® ECM® for Femoral Arterial Reconstruction

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02418156
Other study ID # 14-PR-1120
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 2015
Est. completion date March 2018

Study information
Verified date July 2023
Source Aziyo Biologics, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To gather information on the use of CorMatrix ECM for Vascular Repair in the reconstruction of the femoral artery.

Description:

OBJECTIVE The objective of the study is to actively gather additional information on the use of CorMatrix ECM for vascular repair in the reconstruction of the femoral artery. The CorMatrix ECM for Vascular Repair may be used for patch closure of vessels, as a pledget, or for suture line buttressing when repairing peripheral vessels.

Recruitment information / eligibility
Status Completed
Enrollment 38
Est. completion date March 2018
Est. primary completion date March 2018
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: 1. Subjects must be undergoing femoral arterial reconstruction with patch angioplasty closure 2. Surgeon intends to use CorMatrix ECM per FDA cleared Indications for Use 3. Subject possesses ability to provide informed consent 4. Subject expresses understanding and willingness to fulfill all expected requirements of protocol Exclusion Criteria: 1. Known sensitivity to porcine material

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• CorMatrix ECM for Vascular Repair
Standard femoral arterial interventional procedure using CorMatrix ECM for vascular repair.

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Aziyo Biologics, Inc.

Outcome
Type Measure Description Time frame Safety issue
Primary Device-Related Adverse Events Proportion of patients experiencing device related adverse events. Up to 12 months follow-up
See also
  Status Clinical Trial Phase
Recruiting NCT05335525 - Post-market Clinical Investigation of the Angio-Seal™ VIP VCD (ANGIO-SEAL CLOSE)
Active, not recruiting NCT01903044 - Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia Treating Phase 1/Phase 2
Completed NCT02271529 - Zilver PTX Delivery System N/A
Completed NCT02228564 - BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease N/A
Recruiting NCT02054871 - RCT to Evaluate the Renal Protective Effects of Remote Ischaemic Preconditioning in Peripheral Angioplasty N/A
Completed NCT00822172 - Evaluation of Cilostazol in Combination With L-Carnitine Phase 4
Completed NCT00574782 - Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE) N/A
Completed NCT00029991 - Extract of Ginkgo Biloba (EGB 761) and Vascular Function Phase 1/Phase 2
Completed NCT01355406 - Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System N/A
Recruiting NCT05804097 - Does Increasing Oxygen Nurture Your Symptomatic Ischemic Ulcer Sufficiently? Phase 4
Recruiting NCT03638115 - The VaSecure BTK Study N/A
Active, not recruiting NCT03241459 - Safety and Efficacy of the SurVeil™ Drug-Coated Balloon N/A
Active, not recruiting NCT01661231 - Study to Determine the Performance of the Astron and Pulsar-18 Stents in Europe N/A
Completed NCT01722877 - JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions N/A
Completed NCT01444378 - Absolute Pro® MOMENTUM™ N/A
Completed NCT00753337 - The ACTIVE (Use of the Assurant® Cobalt Iliac Stent System in the Treatment of Iliac Vessel Disease) Study N/A
Completed NCT00538226 - Evaluation of the Effect of the Flowaid Device in Increasing Local Circulation in the Leg Phase 1
Completed NCT00593385 - Atrium iCAST Iliac Stent Pivotal Study N/A
Recruiting NCT00385385 - RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease Phase 2
Completed NCT00392509 - ALD-301 for Critical Limb Ischemia, Randomized Trial Phase 1/Phase 2